Table 4 Studying sADO, sPD-L1, and sPD-1 correlations with the other studied parameters among all mature B-cell lymphoma patients:
From: Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
Mature B-cell lymphoma | sADO | sPD-1 | sPD-L1 | |||
|---|---|---|---|---|---|---|
r | p-value | r | p-value | r | p-value | |
CD38 Degree | 0.702** | 0.000 | 0.565** | 0.000 | 0.425** | 0.000 |
sPD-L1 (ng/L) | 0.318** | 0.002 | 0.600** | 0.000 | ||
sPD-1(ng/L) | 0.498** | 0.000 | 0.600** | 0.000 | ||
sADO (ng/ml) | 0.498** | 0.000 | 0.318** | 0.002 | ||
Age (years) | 0.042 | 0.691 | 0.022 | 0.840 | 0.136 | 0.201 |
WBC (x103/ul) | − 0.185 | 0.080 | − 0.010 | 0.928 | − 0.102 | 0.339 |
LYMPH (x103/ul) | − 0.180 | 0.090 | − 0.050 | 0.639 | − 0.106 | 0.321 |
HB (g/dl) | − 0.266* | 0.011 | − 0.074 | 0.490 | 0.154 | 0.147 |
PLT (x103/ul) | − 0.413** | 0.000 | − 0.110 | 0.300 | 0.082 | 0.440 |
BM.LYM (%) | 0.037 | 0.732 | − 0.050 | 0.642 | − 0.145 | 0.172 |
